Anthrax antigen Other names: Bacillus anthracis antigen Anthrax vaccine

Active ingredient description

Anthrax antigen induces antibodies raised against PA that may contribute to protection by neutralizing the activities of the cytotoxic lethal toxin and edema toxin of Bacillus anthracis.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
J07AC01 Anthrax antigen J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AC Anthrax vaccines
Discover more medicines within J07AC01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
BIOTHRAX Suspension for injection FDA, National Drug Code (US) MPI, US: SPL/PLR

External identifiers

DrugBank Drug: DB11003
RxNorm Ingredient: 1368371
SNOMED-CT Concept: 409499007
Protective antigen of anthrax toxin (substance)
UNII Identifier: OSR4FXO1IU
ANTHRAX PROTECTIVE ANTIGEN

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.